OGN:NYSE
Organon & Co
USDÂ 13,90
arrow_upward
+0,04%(+0,0050) 1D
USDÂ 13,90
0,00% (0,00)
todayPre-market
Closed: 13 Nov., 16:00:03 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for OGN...
Open
USDÂ 13,90
High
USDÂ 13,90
Low
USDÂ 13,88
Mkt. cap
3,65Â mjd
Avg. vol.
2,46Â m
Volume
608,00
Dividend
0,58%
Quarterly dividend
USDÂ 0,02
Ex-dividend date
14 Aug. 2026
P/E ratio
18,08
52-wk high
USDÂ 13,90
52-wk low
USDÂ 5,69
EPS
USDÂ 0,77
Beta
1,53
Shares outstanding
262,62Â m
No. of employees
10Â k
Open
USDÂ 13,90
High
USDÂ 13,90
Low
USDÂ 13,88
Mkt. cap
3,65Â mjd
Avg. vol.
2,46Â m
Volume
608,00
Dividend
0,58%
Quarterly dividend
USDÂ 0,02
Ex-dividend date
14 Aug. 2026
P/E ratio
18,08
52-wk high
USDÂ 13,90
52-wk low
USDÂ 5,69
EPS
USDÂ 0,77
Beta
1,53
Shares outstanding
262,62Â m
No. of employees
10Â k
News stories
From web sources and news partners
Quantisnow
·
10 minute gelede
Adagio Medical Reports Third Quarter 2026 Results
Opening Bell Daily
·
22 minute gelede
Berkshire stock: beat the S&P 500 in every dot-com bust year
StreetInsider
·
5 minute gelede
VEON outlines 2030 growth targets at capital markets day
Benzinga
·
1 uur gelede
12 Industrials Stocks Moving In Monday's Pre-Market Session
Profile
Organon & Co. is an American pharmaceutical company originally founded in Oss, The Netherlands and now headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy, and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States. Wikipedia
About Organon & Co
CEO-
Employees10Â k
Founded1923
HeadquartersJersey City, New Jersey, Verenigde State van Amerika
SectorHealth Care
IndustryPharmaceutical industry
Websiteorganon.com